Different lesions have been suggested to represent preneoplastic conditions in human liver. They include liver cell dysplasia, separated in large-cell change (LCC) and small-cell change (SCC), adenomatoid hyperplasia, and the more recently identified foci of altered hepatocytes (FAH) and nodules of altered hepatocytes (NAH). FAH have been demonstrated to represent preneoplastic lesions in various animal models of hepatocarcinogenesis. To demonstrate prevalence and significance of FAH in the human liver, the cellular composition, size distribution, and proliferation kinetics of these lesions were studied in 163 explanted and resected human livers with or without hepatocellular carcinoma (HCC). FAH including glycogen-storing foci (GSF), mixed cell foci (MCF), and basophilic cell foci were found in 84 of 111 cirrhotic livers, demonstrating higher incidences in cases with than without HCC. MCF, predominant in cirrhotic livers of the high-risk group, were more proliferative, larger and more often involved in formation of NAH than GSF. The results suggest that the FAH are preneoplastic lesions, MCF being more advanced than GSF. We also investigated the relationship of FAH to liver cell dysplasia. Occurrence of SCC, rather than that of LCC, confers FAH an increased proliferation activity and higher risk to nodular transformation, and, hence, should be considered a precancerous condition. Histological detection of FAH and SCC through needle-aspiration liver biopsy can be used for monitoring HCC development in high-risk populations, such as HBV carriers with chronic hepatitis and/or cirrhosis.
INTRODUCTION
Hepatocellular carcinoma (HCC) is currently the fifth most common human cancer in the world (43, 700 new cases annually) (51) . Chronic infection with the hepatitis B virus (HBV) or the hepatitis C virus (HCV), ingestion of food contaminated with chemical carcinogens, especially aflatoxin B 1 , and alcoholic beverages are considered major risk factors for HCC development (8, 14, 18) . Molecular analyses have shown that activation of some proto-oncogenes and genes for growth factors and mutations of the p53 gene or dysfunction of its encoded protein may play a role in certain stages of human hepatocarcinogenesis (8, 30, 59, 63, 66) . Different lesions have been suggested to represent preneoplastic conditions in human liver. They include liver cell dysplasia, separated in large-cell change (LCC) and small-cell change (SCC), adenomatoid hyperplasia, and the more recently identified foci of altered hepatocytes (FAH) and nodules of altered hepatocytes (NAH) (57) . It remains to be settled as to whether cirrhosis itself is a precancerous change, even though this has been held for a long time (67) . Here, we focus on recent approaches to liver cell dysplasia, FAH, and NAH. Other lesions, particularly adenomatoid hyperplasia, have been discussed intensively elsewhere (13, 26, 33, 34, 37, 41, 45, 50) , and hence are not be reviewed here in detail.
to a few phenotypic cellular changes including nuclear and cytoplasmic enlargement, nuclear pleomorphism, and multinucleation. A similar lesion was also described in transgenic mouse livers coexpressing c-myc and transforming growth factor α, which is prone to develop a high incidence of HCC (54) , but the role of LCC for hepatocarcinogenesis under this experimental condition has not been clarified. As LCC is frequently observed in human cirrhotic livers bearing HCC, it has been regarded as a precancerous lesion by some authors (4, 12, 17, 39) . However, the accumulating data from several laboratories do not lend support to this notion. Its high prevalence has been reported also in many chronic liver diseases without an increased risk to develop HCC ( Figure 1 ) (2, 46, 58) . Second, the cytoplasmic/nuclear ratio remains normal for most of the hepatocytes with LCC (31, 72) . Third, these cells were found to have a lower proliferative activity compared with the surrounding liver parenchyma (19, 54, 58, 65, 72) . In addition, the cells with LCC rarely form a focus or a nodular lesion compressing the surrounding tissue (57, 58) . LCC may indeed result from a disturbance in hepatocellular replication, as previously suggested by Altmann (2) and Su et al (65) .
Small-Cell Change of Liver Parenchyma
SCC, originally called "liver cell dysplasia of small-cell type," was described in HBV-associated cirrhosis and chronic hepatitis by Watanabe et al (72) in 1983. It was defined as a set of cytological changes, including small cell size, nuclear pleomorphism, and increased nuclear/cytoplasmic ratio. Data from several groups indicate a close link between SCC and HCC (57) . The liver parenchyma occupied by SCC shows cytological and histological similarities with early, well-differentiated HCC (26, 37, 72, 77) . The hepatic 126 plates involved may reach 2 to 3 layers or form pseudoglandular structures resembling those often observed in welldifferentiated HCC as originally described by Edmondson and Steiner (21) . In general, SCC was found more frequently in livers with than without HCC (58, 65) . Early HCCs often share SCC with foci and nodules of altered hepatocytes (FAH and NAH) as described in detail next (58) . However, SCC is a heterogeneous entity, the identification of which may be difficult; its significance for hepatocarcinogenesis remains to be fully established in view of the recent disapproving data from Libbrecht et al (39) .
In the parenchyma SCC may be distributed in small clusters, in some cases possibly corresponding to the small hepatocytes described previously (60) . Zhao et al (77) divided SCC into "small regenerating liver cells" and "small liver cell dysplasia." Su et al (58) proposed to subtype SCC according to its appearance in the extrafocal parenchyma and in preneoplastic focal or nodular parenchymal lesions, and to grade it into mild (low-grade) and severe (high-grade) forms referring to criteria of an International Working Party (34) .
Preneoplastic Foci of Altered Hepatocytes
FAH were found in several animal species in the early stages of hepatocarcinogenesis caused by chemicals, radi-ation, and chronic infection with hepadnaviruses (8) . Their preneoplastic nature has been well documented, with preneoplasia defined as phenotypically altered cell populations that have no neoplastic nature but are endowed with an increased risk of developing into both benign and/or malignant neoplasms (7) . Similar lesions have been observed fortuitously in the livers of women with a long-term use of oral contraceptives and in other pathologic conditions (3, 5, 15, 27, 32, 35) , particularly in genetic haemochromatosis (20) . Recently, Bannasch et al (10) described the biochemical phenotype of human FAH, mainly including glycogen-storing clear cell foci and clear cell-predominated mixed cell foci, in more than 50% of cirrhotic livers with or without HCC. In an extended study on 163 explanted or resected livers, various types of FAH were characterized regarding their morphological phenotype and proliferation kinetics (58) . In this series, most (32/36, 89%) of the HCCs were observed in liver cirrhoses, mainly caused by HBV or HCV infection or by alcoholic liver disease, constituting a high-risk group for the development of HCC. As shown in Figure 1 , FAH and NAH were observed in 111 of the 163 (68%) livers examined, their incidence in cirrhotic livers bearing HCC (29/32, 91%) being significantly higher than in those without HCC (55/79, 70%) ( p < 0.05). Among HCC-free cirrhoses with known causes (n = 68), the incidence of FAH in cirrhoses associated with high-risk factors (37/47, 79%) was still higher than in primary biliary cirrhosis, and in cirrhosis due to autoimmune hepatitis and other known associations (12/21, 57%) ( p < 0.05). The latter included 3 cases of Byler's disease, 2 cases of Budd-Chiari's syndrome, 1 case of genetic haemochromatosis, 1 case of α-1-antitrypsin deficiency and 1 case of Wilson's disease. All of these diseases were reported to confer a low risk for the development of HCC (20, 23, 44, 48, 49, 52, 70) , and were pooled in the low-risk group for statistical analysis. The results provided evidence for a high incidence of different types of FAH in various kinds of liver diseases. FAH of clear and mixed cell types were observed in almost all livers bearing HCC, and in chronic liver diseases without HCC but at a lower frequency. In HCC-free cirrhosis, the incidence of FAH was found to be significantly higher in the high-risk group than in the low-risk group. These results strongly support the view that FAH, particularly glycogen-storing foci (GSF; Figure 2A , B) and all types of mixed cell foci (MCF), and the resulting hyperproliferative nodular lesions ( Figure 2C , D), are associated with HCC development in man (3, 10) .
It has been pointed out that FAH in rodent liver have different phenotypes and that these phenotypes tend to change sequentially during hepatocarcinogenesis (8) . GSF represent early lesions, with the potential to progress to more advanced glycogen-poor basophilic cell lesions through MCF or some other intermediates (6) . An inverse correlation between glycogen accumulation and cell proliferation has been observed for this process (76) . In our human specimens (58), GSF were observed in a broad spectrum of liver diseases, even in some donor livers with perivenular fibrosis indicative of chronic damage, perhaps from alcohol abuse (55) . However, GSF observed in cirrhotic livers were significantly larger and more variable in size than those in the slightly disordered "control livers." As shown in Figure 3 , the GSF without SCC had a lower proliferative activity than the extrafocal parenchyma, demonstrating that growth control of hepatocytes is muted in these FAH. On the contrary, GSF with SCC ( Figure 2E , F) were phenotypically similar to the intermediate cell foci observed in rodents (8) , and demonstrated a higher proliferative activity and a more frequent nodular transformation (formation of NAH), indicating that these lesions represent a more advanced stage of neoplastic transformation. In human liver, a positive correlation was demonstrated between the hyperproliferation of hepatocytes and a reduction in cell size, this SCC resulting in an increase in cell density in GSF and clear/amphophilic or clear/basophilic mixed cell foci, but not in the extrafocal parenchyma (58) .
The finding of MCF mainly in the livers with high-risk or cryptogenic cirrhosis indicates that these are more advanced precursor lesions in man, in line with earlier observations in experimental animals (8) . Considering their preferential emergence in cirrhotic livers of the high-risk group (Figure 1) , their unequivocally elevated proliferative activity (Figure 3) , and the resulting large size with frequent nodular transformation, we suggest that mixed cell populations are endowed with a high potential to progress to HCC in humans (58) , as previously shown in rats (22, 73) . The fact that SCC was observed in 25% (99/393) of the clear/amphophilic mixed cell foci, and 52% (31/60) of the clear/basophilic mixed cell foci, but only in 14% (44/306) of GSF also suggests that MCF are more instable. Close association between SCC and more advanced FAH indicates that FAH often progresses to HCC through SCC. The presence of SCC in all basophilic cell foci observed implies that FAH of this type are a late preneoplastic lesion. We think that uneven growth of liver parenchyma, caused by the emergence of different types of FAH with an altered growth control is a crucial step in HCC development.
As shown in Figure 1 , clusters of hepatic oncocytes (oncocytic foci) were also observed in the human liver specimens, mainly in cirrhotic livers (18/111) with a preferential occurrence in HBV-associated cirrhosis (9/28). In addition, irregular areas of liver parenchyma with marked cytoplasmic amphophilia, phenotypically similar to the amphophilic preneoplastic foci in rodent liver exposed to different hepatocarcinogenic chemicals (8, 42) or to hepadnaviruses (9, 53) , were present in 45% of the specimens from cirrhotic livers examined. However, more data are needed to elucidate the nature of these oncocytic and amphophilic lesions regarding their role in human HCC development.
Small-Cell Change Is Involved in Progression from the Preneoplastic to the Neoplastic Phenotype
In the study by Su et al (58), the relationships of FAH and NAH to liver cell dysplasia were evaluated, taking into account 2 types of SCC, namely intrafocal and extrafocal, diffuse SCC. Intrafocal SCC was found in 25.2% (28/111) of the cirrhotic livers, mainly in those associated with HBV or HCV infection, or alcoholic liver disease. Based on its highly preferential occurrence in the HCC-bearing livers (52.8%, 19/36; Figure 1 ) and its positive correlation with an elevated proliferative activity (Figure 2E and F) and nodular transformation of the preneoplastic focal lesions, intrafocal SCC may be regarded as a relatively late event in neoplastic development, occurring during conversion of preneoplastic into benign (precancerous) or even malignant neoplastic lesions. Diffuse SCC, on the other hand, was observed mainly within large areas of extrafocal parenchyma. This type of SCC was only found in primary biliary cirrhosis, primary sclerosing cholangitis, and cirrhosis due to autoimmune hepatitis, and may be identical to the parenchymal changes described by Nakanuma and Hirata (43) . The proliferative activity of extrafocal hepatocytes with SCC was not significantly different from those without SCC. It is, hence, unlikely that diffuse SCC is a preneoplastic lesion (58) . It may rather represent an adaptive change associated with cholestasis and periportal hepatocellular injury.
Recently, Libbrecht et al (38) observed immunoreactivities for cytokeratin (CK) 7, CK19, and OV-6, all of which are regarded as markers for ductular (oval) cells, in about half of the focal liver lesions showing SCC. The authors speculated that SCC might emerge from ductular "progenitor" cells. However, no unequivocal evidence for this notion has been provided. Expressions of both CK19 and CK7 have been found in hepatocytes in progressive chronic liver diseases and in some hepatocellular carcinomas in man and rat (40, 59, 61, 71) . The aberrant CK19 expression has been linked to an abnormal deposition of laminin in hepatic sinusoids (59) . Recent results from this group show that laminin, either of exogenous origin or produced intrinsically, can induce the Vol. 31 Differential diagnosis between the preneoplastic focal and nodular hepatic lesions showing (high-grade) SCC and welldifferentiated HCC is of great clinical importance, but sometimes challenging. (High-grade) SCC refers to large FAH or NAH composed of small hepatocytes with pronounced nuclear and architectural deviations from the normal state, but without sufficient features of malignancy to allow a definite diagnosis of HCC. As suggested by the International Working Party (34) , an increase of cellular density of 2-fold compared to the surrounding parenchyma, hepatic plates more than 3 cells-thick with a disturbed arrangement, and an expansive or invasive growth pattern are used as diagnostic indicators of HCC (Edmondson-Steiner grade I).
Problems and Perspectives
Although the development and progression of FAH in human liver, including glycogenotic and mixed cell foci, have been linked with characteristic metabolic and morphological changes (10, 64) , the underlying molecular mechanisms are largely unknown. HBV x protein, whose oncogenic capacity has been repeatedly demonstrated (57) , is present in human preneoplastic FAH, though its expression is not confined to the lesions (62) . During chemical hepatocarcinogenesis in the rat, overexpression of the insulin receptor, the insulin receptor substrate-1, and other components of the insulinstimulated signaling cascade was observed preferentially in glycogenotic hepatocytes of preneoplastic FAH (11, 47) , and has been proposed to be responsible for the excessive accumulation of glycogen in these cells. Reactivation of gene coding for insulin-like growth factor II was found in basophilic (glycogen-poor) FAH and some hyperplastic nodules resembling NAH in woodchuck and human livers chronically infected with woodchuck hepatitis virus and HBV, respectively, and were, hence, attributed to the development and progression of FAH (59, 74) . p53 gene mutations (30) and binding of p53 to HBV x protein (24) have been suggested as alternative mechanisms in human hepatocarcinogenesis (25) , both processes resulting in a nuclear accumulation of p53 protein, allowing its immunohistochemical detection (16, 69) . However, no p53 mutation was detected in 354 FAH and NAH, and a p53-x protein binding was not approved in a recent study (63) . Therefore, neither of these molecular changes can be considered an obligatory event in the development and progression of FAH.
In rodents, it has been accepted that the advanced focal lesions showing definite compression of the surrounding parenchyma are neoplastic lesions (hepatocellular adenomas) (29, 56) . Criteria for the identification of these neoplastic lesions in human cirrhotic livers, however, remain to be Vol. 31, No. 1, 2003 established. Our results show that most nodular lesions develop from the mixed cell and glycogenotic FAH with SCC, and that hepatocytes within these nodules are more proliferative than those in the extrafocal parenchyma, and, hence, represent hyperproliferative populations (58) . At least some of these nodules may already be neoplastic. The clonality status of these nodular lesions remains unsettled. Molecular analyses of HBV DNA integration patterns (68, 75) and methylations of the polymorphic X-chromosome-linked phosphoglycerate kinase (1, 36) and androgen receptor (28) gene in female patients have demonstrated a clonal origin for most hepatocellular neoplasms and some cirrhotic nodules. Further work is needed to clarify whether these nodules correspond to NAH. Considering the preneoplastic nature of FAH and NAH and the markedly increased instability of the lesions with SCC, screening for these lesions through liver biopsy is of great significance for secondary prevention of HCC. Preliminary results of histological investigations on fine-needle aspiration biopsies taken from 191 patients with chronic hepatitis B (n = 159) or C (n = 32) by Su et al (unpublished data) revealed that this procedure can be used with great advantage for the detection of FAH (120/191, 63%; Figure 4 ), opening new perspectives for monitoring HCC development in highrisk populations, such as HBV carriers with chronic hepatitis and/or cirrhosis.
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